DGHS STG App
500+
Downloads
Everyone
info
About this app
STG Mobile App: About us
Antimicrobial Resistance is a growing global public health threat that is imposing serious effects on management of the infectious diseases. The World Health Organization (WHO) and other international bodies identified antimicrobial resistance as the biggest emerging threat for the globe, another pandemic. A National Strategy for Antimicrobial Resistance Containment (ARC) in Bangladesh was developed and approved by the National Steering Committee (NSC) and the National Technical Committee (NTC) with further recommendation of developing a National Action Plan (NAP). The causative microbes of common infectious diseases of Bangladesh are resistant to antibiotics, which include acute respiratory infection (ARI), gastrointestinal infection, tuberculosis (TB), urinary tract infections (UTI), neonatal infections (sepsis), ear infections (otitis media), typhoid fever, and skin & soft tissue infections (SSTIs). Due to lack of standard culture facility, diagnosis and treatment of common infections are mostly empirical. Consequently, the information that we need to design evidence-based intervention to contain antibiotic resistance is currently unavailable in Bangladesh. On this backdrop, Bangladesh has developed a National Standard Treatment Guideline (STG) for use of antibiotics for common infectious diseases. USAID Medicines, Technologies and Pharmaceuticals Services (MTaPS) facilitated the development of the guidelines.
USAID MTaPS is also supporting CDC, DGHS to develop a publicly available web-based platform to facilitate dissemination of AMR information, and an app version of the STG in accordance with the developed STG for common infectious diseases.JBRSOFT is providing technical assistance to the CDC under the financial support of MTaPS,-GHSA, USAID project to develop a publicly available web-based platform to facilitate dissemination of AMR information, and an app version of the STG in accordance with the developed STG for common infectious diseases, as well as transforming from a mobile app to a nationally recognized STG app and building practitioners' capacity to increase the use of WHO classification.
Objective of the Mobile App:
• To recommend treatment for common clinical infections requiring antibiotic therapy
• To promote “AWaRe” classification and approach at all levels before prescribing an antibiotic
• To promote rational use of antibiotics.
• To serve as a tool of antimicrobial stewardship in the hospitals.
• Tied all other health professionals to be drawn from central, divisional health offices and district civil surgeon offices and UHCs in common platform for practices.
• To obtain the reserve groups drugs for the future generation.
Users
BMDC Registered MBBS and BDS doctors from different hospitals, diagnostic center and laboratories.
Antimicrobial Resistance is a growing global public health threat that is imposing serious effects on management of the infectious diseases. The World Health Organization (WHO) and other international bodies identified antimicrobial resistance as the biggest emerging threat for the globe, another pandemic. A National Strategy for Antimicrobial Resistance Containment (ARC) in Bangladesh was developed and approved by the National Steering Committee (NSC) and the National Technical Committee (NTC) with further recommendation of developing a National Action Plan (NAP). The causative microbes of common infectious diseases of Bangladesh are resistant to antibiotics, which include acute respiratory infection (ARI), gastrointestinal infection, tuberculosis (TB), urinary tract infections (UTI), neonatal infections (sepsis), ear infections (otitis media), typhoid fever, and skin & soft tissue infections (SSTIs). Due to lack of standard culture facility, diagnosis and treatment of common infections are mostly empirical. Consequently, the information that we need to design evidence-based intervention to contain antibiotic resistance is currently unavailable in Bangladesh. On this backdrop, Bangladesh has developed a National Standard Treatment Guideline (STG) for use of antibiotics for common infectious diseases. USAID Medicines, Technologies and Pharmaceuticals Services (MTaPS) facilitated the development of the guidelines.
USAID MTaPS is also supporting CDC, DGHS to develop a publicly available web-based platform to facilitate dissemination of AMR information, and an app version of the STG in accordance with the developed STG for common infectious diseases.JBRSOFT is providing technical assistance to the CDC under the financial support of MTaPS,-GHSA, USAID project to develop a publicly available web-based platform to facilitate dissemination of AMR information, and an app version of the STG in accordance with the developed STG for common infectious diseases, as well as transforming from a mobile app to a nationally recognized STG app and building practitioners' capacity to increase the use of WHO classification.
Objective of the Mobile App:
• To recommend treatment for common clinical infections requiring antibiotic therapy
• To promote “AWaRe” classification and approach at all levels before prescribing an antibiotic
• To promote rational use of antibiotics.
• To serve as a tool of antimicrobial stewardship in the hospitals.
• Tied all other health professionals to be drawn from central, divisional health offices and district civil surgeon offices and UHCs in common platform for practices.
• To obtain the reserve groups drugs for the future generation.
Users
BMDC Registered MBBS and BDS doctors from different hospitals, diagnostic center and laboratories.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info
Data isn’t encrypted